72%* drop from November peak. See my chart a few posts above.
The kicker is TRIP is down again to $0.30 overnight, so it will have to gain a massive 250% to be a CPH equivalent of $0.30 once the merger happens. It's apparent the last of the CPH holders don't have their math skills up to scratch, gonna be a lonnnnng time before any (if any, I should say) substantial gains that you look for in a micro spec stock.
- Forums
- ASX - By Stock
- Creso Pharma (ASX:CPH) welcomes the Royal Commission and clinical studies on psilocybin
72%* drop from November peak. See my chart a few posts above.The...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CPH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online